SightfileU.S. market data from official filings

PENNANT GROUP INC (PNTG)

Name: PENNANT GROUP INC (PNTG) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001766400 · EDGAR filings · Updated 2026-07-17

PENNANT GROUP INC (PNTG) has reported institutional ownership of 89.4%, with 189 institutional managers holding positions valued at $947.4M per the latest 13F reporting period.

Institutional ownership

89.4%

Institutional managers

189

Reported 13F value

$947.4M

Insider activity

40 trans.

−$278.2K net selling

Latest updates

2026-07-17 — Insider transaction reported (Form 4)
2026-07-17 — Insider transaction reported (Form 4)
2026-07-17 — Insider transaction reported (Form 4)
2026-07-17 — SCHEDULE 13G filed
2026-07-17 — Insider transaction reported (Form 4)
2026-07-17 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PENNANT GROUP INC has 189 institutional holders and institutional ownership of 89.4%.

Insider activity

Insiders reported 40 transactions (0 buys, 4 sells) across 13 reporting insiders, with a net reported value of −$278.2K.

Related companies

NOVAVAX INC (NVAX) · BIOLIFE SOLUTIONS INC COM NEW (BLFS) · FRESENIUS MEDICAL CARE AG (FMS) · NUVATION BIO INC (NUVB) · IOVANCE BIOTHERAPEUTICS INC (IOVA) · FORTREA HLDGS INC (FTRE)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.